The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: A preliminary report

Chinese Medical Journal (Taipei)

Volumn 60, Issue 5, 1997, Pages 229-235

  Chiou, Tzeon Jye ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Advanced cancer; Chemotherapy related anemia; Recombinant human erythropoietin (r HuEPO)

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT ERYTHROPOIETIN;

ACUTE LEUKEMIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED;

EID: 0031429787     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Svanberg E, Sandstrom R, Lundholm K. Anemia in patients with solid malignant tumors. Erythropoietin 1995;6:35-40.
2. Cartwright CE. The anemia of chronic disease. Semin Hematol 1996;3:351-75.